DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
Phase 2
Recruiting
- Conditions
- High Grade GliomaAnaplastic Astrocytoma
- Interventions
- Drug: DB107-RRVDrug: DB107-FC
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Ashish Shah
- Target Recruit Count
- 33
- Registration Number
- NCT06264388
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath